Device Trial Radar · NCT05304819
PMCF Study of the AchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair
Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
19
Actual
Start
Mar 9, 2022
Primary completion
Jan 31, 2026
Study completion Jan 31, 2026
Sponsor
- Lead sponsor
- Xiros LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 31, 2022
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Post Market Clinical Follow Up Study in Orthopaedics, it will verify the long-term safety and performance of the device in the intended patient population, when indicated for the acute repair of the Achilles tendon. The Medical Device in this study AchilloCordPLUS is a Class IIb UKCA-Marked device manufactured by Xiros Ltd.
Conditions
- Achilles Tendon Rupture
Interventions
AchilloCordPLUS™ System ImplantDevice
AchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair
Primary outcomes
What the sponsor says the trial is designed to measure.
- Achilles Tendon Rupture Score (ATRS)Time frame: 6 months
- adverse events (AE)Time frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
North Cumbria Integrated Care Nhs Foundation Trust
Penrith, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.